Jane Street Group, LLC United Therapeutics Corp Put Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $5.16 Million - $6.03 Million	16,600 New	16,600 $5.95 Million
Q1 2022 May 17, 2022	BUY	$166.16 - $213.96 $9.14 Million - $11.8 Million	55,000 Added 617.98%	63,900 $11.5 Million
Q4 2021 Feb 15, 2022	SELL	$184.32 - $216.08 $2.21 Million - $2.59 Million	-12,000 Reduced 57.42%	8,900 $1.92 Million
Q3 2021 Nov 16, 2021	SELL	$179.86 - $214.88 $377,706 - $451,248	-2,100 Reduced 9.13%	20,900 $3.86 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $1.82 Million - $2.27 Million	-10,700 Reduced 31.75%	23,000 $4.13 Million
Q1 2021 May 18, 2021	BUY	$153.94 - $174.85 $3.2 Million - $3.64 Million	20,800 Added 161.24%	33,700 $5.64 Million
Q4 2020 Feb 17, 2021	BUY	$101.87 - $151.79 $621,407 - $925,919	6,100 Added 89.71%	12,900 $1.96 Million
Q3 2020 Nov 17, 2020	SELL	$99.9 - $121.13 $459,540 - $557,198	-4,600 Reduced 40.35%	6,800 $687,000
Q2 2020 Aug 17, 2020	BUY	$92.74 - $125.82 $1.06 Million - $1.43 Million	11,400 New	11,400 $1.38 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.